BioNTech SE (NASDAQ:BNTX)
| 161.04 Delayed Data As of Jul 05 |  +3.53 / +2.24%Today’s Change | 117.08 Today|||52-Week Range 464.00 | -37.53% Year-to-Date |
Latest BNTX News | Press Releases
| Why Moderna Stock Is Jumping Today Jul 05 / MotleyFool.com - Paid Partner Content | Why BioNTech Stock Advanced Today Jun 30 / MotleyFool.com - Paid Partner Content |
| The Zacks Analyst Blog Highlights Pfizer, BioNTec and Moderna Jul 05 / Zacks.com - Paid Partner Content | Pfizer (PFE) Inks Deal With US Government for COVID Jab Supply Jun 30 / Zacks.com - Paid Partner Content |
| Healthcare stocks may keep your portfolio from needing a checkup Jul 03 / CNN.com | The Chef's Warehouse and AZEK have been highlighted as Zacks Bull and Bear of the Day Jun 30 / Zacks.com - Paid Partner Content |
| FDA Recommends Adding New Omicron Subvariants to COVID Boosters Jul 01 / Zacks.com - Paid Partner Content | FDA Panel Recommends Modifying COVID Jabs to Target Omicron Jun 29 / Zacks.com - Paid Partner Content |
| Why Pfizer Popped While the Market Flopped Today Jun 30 / MotleyFool.com - Paid Partner Content | Company News for Jun 28, 2022 Jun 28 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 157.50 |
| Today’s open | 151.37 |
| Day’s range | 151.08 - 162.82 |
| Volume | 1,651,658 |
| Average volume (3 months) | 1,476,732 |
| Market cap | $38.3B |
Data as of 4:00pm ET, 07/05/2022
Growth & Valuation
| Earnings growth (last year) | +67,642.93% |
| Earnings growth (this year) | -10.12% |
| Earnings growth (next 5 years) | -47.80% |
| Revenue growth (last year) | +3,979.40% |
| P/E ratio | 3.2 |
| Price/Sales | 2.98 |
| Price/Book | 2.82 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 8, 2022 |
| EPS forecast (this quarter) | $7.25 |
| Annual revenue (last year) | $22.4B |
| Annual profit (last year) | $12.2B |
| Net profit margin | 54.24% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
